Pulmonary hemorrhage and acute pulmonary thromboembolism after abciximab administration.

作者信息

Conrotto Federico, Scacciatella Paolo, Usmiani Tullio, Grasso Costanza, Ebrille Elisa, D'Amico Maurizio, Marra Sebastiano

机构信息

Department of Cardiology, San Giovanni Battista Hospital, Turin, Italy.

出版信息

Am J Emerg Med. 2013 Feb;31(2):450.e1-2. doi: 10.1016/j.ajem.2012.06.018. Epub 2012 Sep 11.

DOI:10.1016/j.ajem.2012.06.018

PMID:22980359

Abstract

摘要

相似文献

Pulmonary hemorrhage and acute pulmonary thromboembolism after abciximab administration.

Am J Emerg Med. 2013 Feb;31(2):450.e1-2. doi: 10.1016/j.ajem.2012.06.018. Epub 2012 Sep 11.

Abciximab and fatal pulmonary hemorrhage.

Heart Lung. 2006 Nov-Dec;35(6):423-6. doi: 10.1016/j.hrtlng.2006.06.004.

Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.

Am Heart J. 2007 Jul;154(1):158.e1-7. doi: 10.1016/j.ahj.2007.03.050.

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.

Am Heart J. 2004 May;147(5):865-73. doi: 10.1016/j.ahj.2003.11.009.

Abciximab-induced alveolar hemorrhage treated with rescue extracorporeal membranous oxygenation.

Catheter Cardiovasc Interv. 2015 Apr;85(5):828-31. doi: 10.1002/ccd.25731. Epub 2014 Nov 22.

Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.

Circulation. 2010 Dec 21;122(25):2709-17. doi: 10.1161/CIRCULATIONAHA.110.002741. Epub 2010 Nov 15.

How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?

EuroIntervention. 2015 Feb;10(10):e1-6. doi: 10.4244/EIJV10I10A208.

Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.

Circulation. 2003 Sep 16;108(11):1316-23. doi: 10.1161/01.CIR.0000087601.45803.86. Epub 2003 Aug 25.

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

N Engl J Med. 2001 Jun 21;344(25):1888-94. doi: 10.1056/NEJM200106213442502.

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

N Engl J Med. 2001 Jun 21;344(25):1895-903. doi: 10.1056/NEJM200106213442503.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验